Acta Med. 1997, 40: 61-70

https://doi.org/10.14712/18059694.2020.46

Some Serum Activity Markers of Airways Inflammation in Difficult-To-Control Asthma Patients

Bohuslav Krála, Jan Krejseka, Zdena Parákováa, Otakar Kopeckýb, Doris Vokurkováb, Václav Dernerb, Miroslava Touškováb

aIInd Department of Medicine, Charles University, Faculty of Medicine, Hradec Králové, Czech Republic
bDepartment of Clinical Immunology and Allergy, University Teaching Hospital, Hradec Králové, Czech Republic

Received May 1, 1997
Accepted June 1, 1997

References

1. Agostini C, Semenzato G. Immune response in the lung: basic principles. Lung 1990; 168S:1001-12. <https://doi.org/10.1007/BF02718238>
2. Barnes I. Evaluating asthma and its treatment: Clinical markers and indicators of efficacy. Eur Respir Rev 1996; 6:31-2.
3. Barnes PS. New drugs for asthma. Eur Respir J 1992; 5:1126-36.
4. Barnes PS, Holgate ST, Laitinen LA, Pauwels R. Asthma mechanisms, determinants of severity and treatment: the role of nedocromil sodium. Clin Experimental Allergy 1995; 25:771-87. <https://doi.org/10.1111/j.1365-2222.1995.tb00016.x>
5. Beasley R, Burgess C, Crane J et al. Pathology of asthma and its clinical implications. J Allergy Clin Immunol 1993; 92:148-54. <https://doi.org/10.1016/0091-6749(93)90097-Y>
6. Billery L, De Franchis G, Plebani M. Fc E RII/CD-23 expression in atopic subjects during natural allergen exposition. J Allergy 1996; 51(Suppl. 31):107.
7. Borish L, Joseph BZ. Inflammation and the allergic response. Med Clin North Am 1992; 76:765-87. <https://doi.org/10.1016/S0025-7125(16)30325-X>
8. Burrows B, Martinez FD, Halonen M et al. Association of asthma with serum IgE levels and skin test reactivity to allergen. N Engl J Med 1985; 320:217-77.
9. Ceyhan BB, Sungur M, Turgay C et al. Role of adhesion molecule ICAM-1 in asthma. J Asthma 1995; 32:419-27. <https://doi.org/10.3109/02770909409077753>
10. Corrigan CJ, Hartnell A, Kay AB. T-lymphocyte activation in acute severe asthma. Lancet 1988: 1129-33. <https://doi.org/10.1016/S0140-6736(88)91951-4>
11. Corrigan CJ. Elevated interleukin-4 secretion by T-lymphocytes: a feature of atopy or of asthma? N Engl J Med 1985; 320:271-77.
12. De Amici M. Serum soluble CD-23 (sCD-23) levels in patients with allergic respiratory disorders. J Allergol 1996; 51(Suppl. 31):108.
13. deVries JE. Cytokines in Allergy. Conversations in Allergy IV. UCB Institute of Allergy, 1994: 11-2.
14. Drazen JM, Turino GM. Progress at the interface of inflammation and asthma. Am J Respir Crit Care Med 1995; 152:386-7. <https://doi.org/10.1164/ajrccm.152.1.7599852>
15. Eum SY, Heusser C, Lefort J et al. Inhibition of bronchial hyperactivity and eosinophil infiltration into the mouse airways by a non-anaphylactic anti-IgE antibody. Eur Respir J 1996; 9(Suppl. 23):136pp.
16. Frew AJ. The inflammatory basic of asthma. Eur Respir Rev 1996; 6:1-3.
17. Geba GP, Zitnik RJ, Elias JA. Interleukins in the pulmonary inflammatory response. In: Molecular biology of lung disease. Blackwell Scientific Publications: London, 1994: 314-43.
18. Geha M. Regulation of IgE. Conversations in Allergy IV. UCB Institute of Allergy, 1994: 5-6.
19. Holgate ST. Cellular and mediator mechanisms in asthma. UCB Institute of Allergy, 1992: 1-20.
20. Holgate ST, Djukanovič R., Howarth PH. Mucosal inflammation and its clinical consequences. In: Marsh DG, Lockhart A, Holgate S.:The genetics of asthma. Blackwell Scientific Publications:London, 1993: 41-57.
21. Holgate ST. Asthma: past, present and future. Eur Respir J 1993; 6:1507-20.
22. Holgate ST. The inflammation-repair cycle in asthma: possible new biomarkers of disease activity. Eur Respir Rev, 1996; 6:4-10.
23. Howarth PH, Wilson R, Djukanovic R et al. Airway inflammation and atopic asthma: a comparative bronchoscopic investigation. Int Arch Allergy Appl Immunol 1991; 94:266-9. <https://doi.org/10.1159/000235379>
24. Hruškovič I, Kayserová H, Čižnár P, Brezina M. Súčasné názory na patofyziológiu bronchiálnej astmy. Detský lekár 1995; 2(Suppl.):5-8.
25. Chanarin N, Corne J, Holgate ST. Workshop report. Asthma: basis and management at different ages. Respir Med 1995; 89:409-13. <https://doi.org/10.1016/0954-6111(95)90208-2>
26. Irwing R, Curley FJ, French CL. Difficult-to-control asthma. Contributing factors and outcome of a systematic management protocol. Chest 1993; 103:1662-9. <https://doi.org/10.1378/chest.103.6.1662>
27. Jeffery PK, Wardlav AJ, Nelson FC et al. Bronchial biopsies in asthma: an ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989; 140:1745-53. <https://doi.org/10.1164/ajrccm/140.6.1745>
28. Kay AB. T-lymphocytes as effector cells in asthma. In: Marsh DG, Lockhart A, Holgate ST. The genetics of asthma. Blackwell Scientific publications:London, 1993:27-32.
29. Kimura G, Takahashi K, Tada S et al. The role of interferon gamma in pathogenesis of bronchial asthma. XIV International Congress of Allergology and Clinical Immunology, Kyoto, Japan, 1991:33.
30. Kips J. Monitoring cellular activity in allergic airway inflammation. ECACI 95, Monduzzi Editore Bologna, 1995:495-502.
31. Krejsek J, Kopecký O, Fixa B. Adhezivní molekuly a imunologie zánětu. Stud Pneumol Phtiseol 1993; 53:149-55.
32. Krejsek J, Kopecký O, Fixa B. Cytokiny a jejich působení v imunitním systému. Lék Zpr LF UK Hradec Králové 1994; 39:17-25.
33. Krejsek J, Kopecký O, Král B. Imunopatogeneze asthma bronchiale. 1. regulační působení T-lymfocytů syntéza IgE. Stud Pneumol Phtiseol 1996; 56:214-8.
34. Lack G, Renz Saloga J et al. Nebulized but not parenteral INF-gamma decreases IgE production and normalizes airways in murin model of allergen sensitization. J Immunol 1994; 152:2546.
35. Mariani F, Price JF, Kemeny DM. The IgG subclass antibody response to inhalant allergen (D. pteronyssinus) during the first year of life: evidence for early stimulation of the immune system following natural exposure. Clin Exp Allergy 1992; 22:29-35. <https://doi.org/10.1111/j.1365-2222.1992.tb00111.x>
36. Matsumoto K, Taki F, Miura M et al. Serum levels of soluble IL-2R, IL-4 and soluble Fc E RII in adult bronchial asthma. Chest 1994; 105:681-6. <https://doi.org/10.1378/chest.105.3.681>
37. Midander J. Clinical documentation of inflammation markers in asthma. Clin Exp Allergy 1993; 23(Suppl.):13-4. <https://doi.org/10.1111/j.1365-2222.1993.tb00374.x>
38. Montefort S, Lai CK, Kapahi P et al. Circulating adhesion molecules in asthma. Am J Respir Crit Care Med 1994; 149:1149-52. <https://doi.org/10.1164/ajrccm.149.5.7513593>
39. O'Byrne PM. The natural history of asthma. Eur Respir Rev 1996; 6:23-6.
40. Papadopoulos NG et al. Restorement of defective INFgamma production in PBMC of atopic patients by addition of INF-gamma. J Allergy 1996; 51(Suppl. 31):18.
41. Park ChS, Lee SM, Chung SW et al. Interleukin-2 and soluble interleukin-2 receptor in bronchoalveolar lavage fluid from patients with bronchial asthma. Chest 1994; 106:400-6. <https://doi.org/10.1378/chest.106.2.400>
42. Pauwels R. Asthma: managing the underlying disease. Eur Respir Rev 1994; 4:291-4.
43. Pavlovičová E, Michaličková J, Ondrišová M et al. Hladiny cirkulucej intercelulárnej adhezívnej molekuly s ICAM-1 u pacientov s bronchiálnou astmou. Stud Pneumol Phtiseol 1995; 55:380-5.
44. Punnonen J, Carballido JM, Aversa G et al. Inhibition of human IgE synthesis by an IL-4/IL-13 receptor antagonist in vitro and in vivo. ECACI, 1995:29-33.
45. Reaburn D, Webber SE. Proinflammatory potential of the airway epithelium in bronchial asthma. Eur Respir J 1994; 7:2226-33. <https://doi.org/10.1183/09031936.94.07122226>
46. Ricci M. IL-4 a key cytokine in atopy. Clin Exp Allergy 1994; 24:801-12. <https://doi.org/10.1111/j.1365-2222.1994.tb01803.x>
47. Ricci M. Allergic inflammation in asthma. UCB Institute of Allergy, 1994:15-7.
48. Rogalla B, Taszakowski W. Serum level of soluble CD- 23 (sCD-23) in pollinotic and house dust mite sensitive patients undergoing specific immunotherapy. Eur Respir J 1996; 9(Suppl. 23):89pp.
49. Romagnani S. Regulation of human IgE synthesis and its deregulation in atopic subjects. In: The Genetics of Asthma. Blackwell Scientifique Publications, 1993:163-76.
50. Ronchi MC, Piragino C, Rosi E et al. Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD. Thorax 1996; 51:1000-4. <https://doi.org/10.1136/thx.51.10.1000> <PubMed>
51. Sanchez A. Changes in the receptors of activation in lymphocytes T in peripheral blood and in serum (sIL-2R) after allergen challenge. J Allergy 1996; 51(Suppl. 31):100.
52. Shiota Y, Wilson JG, Marukawa M. Soluble intercellular adhesion molecule 1 (ICAM-1) in sera of bronchial asthmatics. Chest 1996; 109:94-9. <https://doi.org/10.1378/chest.109.1.94>
53. Soliman MA, El-Hanna A, El-Hadidi A et al. Soluble interleukin-2 receptor, interleukin-4 and interferon gamma in bronchoalveolar lavage fluid of asthmatic patients. J Allergy 1996; 51(Suppl. 31):292.
54. Sont JK, Van Krieken JM, Evertse ChE et al. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax 1996; 51:496-502. <https://doi.org/10.1136/thx.51.5.496> <PubMed>
55. Vignola AM, Campbell AM, Chanel P et al. HLA-DR and ICAM-1 expression in bronchial epithelial cells in asthma and chronic bronchitis. Am Rev Respir Dis 1993; 148:689-94. <https://doi.org/10.1164/ajrccm/148.3.689>
56. Virchow JCJr, Walker C, Hafner D et al. Cytokine networking in asthmatic inf lammation. Its role in lymphocyte and eosinophile activation. Eur Respir J 1993; 6(S17):514.
57. Virchow JCJr, Kroegel C, Walker C, Matthys H. Cellular and immunological markers of allergic and intrinsic bronchial asthma. Lung 1994; 172:313-34. <https://doi.org/10.1007/BF00172846>
58. Vondra V. Reisová M. Prevalence bronchiálního astmatu stoupá, mortalita kolísá. Cas Lek Cesk 1996; 135:471-6.
59. Wagner CD, Rothlein R, Clarke CC et al. Inhaled anti-ICAM-1 reduces antigen-induced airway hyperresponsiveness in monkeys. (Abstract). Am Rev Respir Dis 1991; 143:A418. <https://doi.org/10.1164/ajrccm/143.4_Pt_1.883>
60. Walker C, Bode E, Boer L et al. Allergic and nonallergic asthmatics have distinct patterns of T cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992; 146:109-15. <https://doi.org/10.1164/ajrccm/146.1.109>
61. Wein M, Bochner BS. Adhesion molecule antagonists: future therapies for allergic diseases? Eur Respir J 1993; 6:1239-42.
62. Wierenga EA, Snoek M, Bos JD et al. Comparison of diversity of house dust mite-specific T-lymphocyte clones from atopic and nonatopic donors. Eur J Immunol 1990; 20:1519-26. <https://doi.org/10.1002/eji.1830200717>
63. Wierenga EA, Snoek M, DeGroot C et al. Evidence for compartmentalization of functional subsets of CD-4+ T lymphocytes in atopic patients. J Immunol 1990; 144:4651-60.
64. Wilkinson J, Holgate ST. Candidate gene loci in asthmatic and allergic inflammation. Thorax 1996; 51:3-8. <https://doi.org/10.1136/thx.51.1.3> <PubMed>
65. Zervaki E, Papadopoulos NG, Androani E et al. INFgamma and IL-4 production in atopic children. J Allergy 1996; 51(Suppl.31):148.
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive